The mechanism study of THBS3 in regulating cartilage vascularization/bone coupling via the TGF-β/Smad2/3 pathway in osteoarthritis

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objective Vascularization and osteogenesis coupling is observed in osteoarthritis (OA) cartilage. THBS-3 belongs to the extracellular matrix (ECM) proteins and is highly expressed in cartilage tissue. The effect of THBS-3 on OA is unclear. This study aims to explore the mechanistic role of THBS-3 in OA. Design: Expressions of THBS-3 was detected by Western blot (WB) and RT-qPCR. WB was employed to measure the expression levels of synthesis and degradation metabolism, as well as vascularization/ossification coupling. Migration and tube formation experiments were conducted to assess the migratory and tube-forming abilities of HUVECs influenced by THBS-3. Micro-CT was utilized for 3D imaging in mice. Immunohistochemistry was employed to detect the expression of synthesis, degradation metabolism, and vascularization/ossification coupling-related markers. Additionally, WB was utilized to assess the transforming growth factor-beta (TGF-β) signaling pathway. Results Proteinomics sequencing has revealed a higher expression level of THBS-3 in OA cartilage. Chondrocytes from OA joints exhibited significantly higher expression of THBS-3 relative to healthy individuals. In experiments conducted both in vivo and in vitro, THBS-3 exhibited a dual impact by enhancing catabolic metabolism, suppressing synthetic metabolism, and fostering the coupling of vascularization and osteogenesis within the cartilage. THBS-3 activated the TGF-β signaling pathway, and blockade of the TGF-β signaling pathway resulted in increased p-Smad2/3 expression in OA cartilage cells and decreased expression of vascularization /ossification coupling. Conclusion THBS-3 can promote the vascularization/ossification coupling of cartilage cells by activating the TGF-β/Smad2/3 signaling pathway, providing new insights and targets for the treatment of OA.

Article activity feed